Ctdna Monitoring: 8 Real Stories

8 stories match ctdna monitoring. 5 of them mention radiation.

Kevin, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Kevin's Survivor Story

Patient Info: Kevin, Male, 50s | Stage III

Biomarkers: Tumor DNA used to create custom blood test for ctDNA monitoring; no actionable biomarker reported

No issues or signs of recurrence 2.5 years after finishing chemotherapy, with clean colonoscopy 1 year after surgery and ongoing liquid-biopsy monitoring.

Colorectal Cancer Alliance
OutcomeCancer-Free / NED
Michelle, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of Hope
OutcomeCancer-Free / NED
David, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: David's Patient Story

Patient Info: David, Male | Stage IV

Metastatic Site: Liver; lung; tailbone/bone

Had clear scans after multiple treatments for recurrent Stage IV colon cancer, but a later positive Signatera test suggested possible microscopic disease and more treatment was being planned.

The Patient Story
OutcomeCare Ongoing
Natasha, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Natasha's Patient Story

Patient Info: Natasha McCants, Female, 40s | Stage IV

Biomarkers: Unspecified tumor mutation identified by molecular testing

Metastatic Site: Liver; lungs; ovary

As of February 2026, Natasha’s Stage IV colorectal cancer was under control after mutation-informed treatment at City of Hope, but Signatera showed potentially active cells and she remained on daily chemotherapy pills.

City of Hope
OutcomeResponding Well
Cora, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Cora's Patient Story

Patient Info: Cora, Female | Stage IV

Metastatic Site: Liver; lungs

As of February 2026, Cora had recurrent Stage IV colorectal cancer with a positive ctDNA test but clear CT imaging after stopping an immunotherapy trial because of toxicity, so ongoing care and monitoring were still needed.

The Patient Story
OutcomeCare Ongoing
Andrea, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III colorectal cancer: remission after treatment

Patient Info: Andrea, Female, Under 40 | Stage III

As of May 2024, Andrea described being in remission since June 2022, with no cancer seen on follow-up scans and tumor DNA tests remaining negative during close 3-month surveillance.

The Patient Story
OutcomeCancer-Free / NED
Sherri, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Sherri's Patient Story

Patient Info: Sherri, Female | Stage IV

Biomarkers: BRCA1-negative

Metastatic Site: Bone marrow

As of November 2023, Sherri had no evidence of disease on recent breast cancer scans but remained on targeted treatment every 3 weeks and had started oxaliplatin after surgery for a separate Stage III colon cancer.

The Patient Story
OutcomeCare Ongoing
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

My Stage 4 Colorectal Cancer Story: How I Never Lost Hope

Patient Info: Jason Randall, Male | Stage IV

Metastatic Site: Liver; lungs; bone/sacrum

As of June 2023, Jason had a negative Signatera test, CT scans showing 9 months with no evidence of disease, and about 2.5 years off chemotherapy after Stage IV colorectal cancer treatment and lung ablation.

The Patient Story
OutcomeCancer-Free / NED